Post-Marketing Safety Surveillance of Tofacitinib over 9 Years in Patients with Psoriatic Arthritis and Rheumatoid Arthritis

被引：0
|
作者：
Gerd R. Burmester
Laura C. Coates
Stanley B. Cohen
Yoshiya Tanaka
Ivana Vranic
Edward Nagy
Irina Lazariciu
All-shine Chen
Kenneth Kwok
Lara Fallon
Cassandra Kinch
机构：
[1] Charité-Universitätsmedizin Berlin,Department of Rheumatology and Clinical Immunology
[2] University of Oxford,Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences
[3] Botnar Research Centre,Metroplex Clinical Research Center and Department of Internal Medicine
[4] The University of Texas Southwestern Medical Center,First Department of Internal Medicine
[5] University of Occupational and Environmental Health Japan,Inflammation and Immunology
[6] Pfizer Ltd,undefined
[7] Pfizer Inc,undefined
[8] Pfizer Inc,undefined
[9] Pfizer Canada ULC,undefined
来源：
Rheumatology and Therapy | 2023年 / 10卷
关键词：
Post-marketing surveillance; Psoriatic arthritis; Rheumatoid arthritis; Safety; Tofacitinib;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1255 / 1276
页数：21
相关论文
共 50 条
  • [1] POST-MARKETING SAFETY SURVEILLANCE OF TOFACITINIB OVER 9 YEARS IN PATIENTS WITH RHEUMATOID ARTHRITIS AND PSORIATIC ARTHRITIS
    Burmester, G. R.
    Coates, L.
    Cohen, S. B.
    Tanaka, Y.
    Vranic, I.
    Nagy, E.
    Chen, A. S.
    Lazariciu, I.
    Kwok, K.
    Fallon, L.
    Kinch, C.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 347 - 348
  • [2] Post-Marketing Safety Surveillance of Tofacitinib over 9 Years in Patients with Psoriatic Arthritis and Rheumatoid Arthritis
    Burmester, Gerd R.
    Coates, Laura C.
    Cohen, Stanley B.
    Tanaka, Yoshiya
    Vranic, Ivana
    Nagy, Edward
    Lazariciu, Irina
    Chen, All-shine
    Kwok, Kenneth
    Fallon, Lara
    Kinch, Cassandra
    [J]. RHEUMATOLOGY AND THERAPY, 2023, 10 (05) : 1255 - 1276
  • [3] Correction: Post-Marketing Safety Surveillance of Tofacitinib over 9 Years in Patients with Psoriatic Arthritis and Rheumatoid Arthritis
    Gerd R. Burmester
    Laura C. Coates
    Stanley B. Cohen
    Yoshiya Tanaka
    Ivana Vranic
    Edward Nagy
    Irina Lazariciu
    All-shine Chen
    Kenneth Kwok
    Lara Fallon
    Cassandra Kinch
    [J]. Rheumatology and Therapy, 2024, 11 (1) : 221 - 222
  • [4] Safety and effectiveness of tofacitinib in Korean adult patients with rheumatoid arthritis: A post-marketing surveillance study
    Ju, Ji Hyeon
    Sung, Yoon-Kyoung
    Jo, Joo-young
    Jeon, Ja-Young
    Yoo, Hyun-Jeong
    Lee, Eun Bong
    [J]. MODERN RHEUMATOLOGY, 2023, 33 (06) : 1087 - 1096
  • [5] POST-MARKETING SURVEILLANCE OF TOFACITINIB IN JAPANESE PATIENTS WITH RHEUMATOID ARTHRITIS: AN INTERIM REPORT OF SAFETY DATA
    Tamura, N.
    Kuwana, M.
    Atsumi, T.
    Takei, S.
    Harigai, M.
    Fujii, T.
    Matsuno, H.
    Mimori, T.
    Momohara, S.
    Yamamoto, K.
    Nomura, K.
    Endo, Y.
    Sugiyama, N.
    Hirose, T.
    Morishima, Y.
    Yoshii, N.
    Takagi, M.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1408 - 1408
  • [6] Post-Marketing Surveillance of Tofacitinib in Japanese Patients with Rheumatoid Arthritis: An Interim Report of Safety Data
    Mimori, Tsuneyo
    Harigai, Masayoshi
    Atsumi, Tatsuya
    Kuwana, Masataka
    Takei, Syuji
    Tamura, Naoto
    Fujii, Takao
    Matsuno, Hiroaki
    Momohara, Shigeki
    Yamamoto, Kazuhiko
    Kokubo, Takeshi
    Endo, Yutaka
    Sugiyama, Naonobu
    Hirose, Tomohiro
    Morishima, Yosuke
    Yoshii, Noritoshi
    [J]. ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [7] POST-MARKETING SURVEILLANCE OF TOFACITINIB IN JAPANESE PATIENTS WITH RHEUMATOID ARTHRITIS: AN INTERIM REPORT OF SAFETY DATA
    Mimori, T.
    Harigai, M.
    Atsumi, T.
    Kuwana, M.
    Takei, S.
    Tamura, N.
    Fuji, T.
    Matsuno, H.
    Momohara, S.
    Yamamoto, K.
    Kokubo, T.
    Endo, Y.
    Sugiyama, N.
    Hirose, T.
    Morishima, Y.
    Yoshii, N.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1200 - 1201
  • [8] Six-month safety and effectiveness of tofacitinib in patients with rheumatoid arthritis in Japan: Interim analysis of post-marketing surveillance
    Kuwana, Masataka
    Sugiyama, Naonobu
    Momohara, Shigeki
    Atsumi, Tatsuya
    Takei, Syuji
    Tamura, Naoto
    Harigai, Masayoshi
    Fujii, Takao
    Matsuno, Hiroaki
    Takeuchi, Tsutomu
    Yamamoto, Kazuhiko
    Takasaki, Yoshinari
    Tanigawa, Miki
    Endo, Yutaka
    Hirose, Tomohiro
    Morishima, Yosuke
    Yoshii, Noritoshi
    Mimori, Tsuneyo
    Takagi, Michiaki
    [J]. MODERN RHEUMATOLOGY, 2024, 34 (02) : 272 - 286
  • [9] Worldwide, 3-Year, Post-Marketing Surveillance Experience with Tofacitinib in Rheumatoid Arthritis
    Stanley Cohen
    Jeffrey R. Curtis
    Ryan DeMasi
    Yan Chen
    Haiyun Fan
    Arif Soonasra
    Roy Fleischmann
    [J]. Rheumatology and Therapy, 2018, 5 : 283 - 291
  • [10] Worldwide, 3-Year, Post-Marketing Surveillance Experience with Tofacitinib in Rheumatoid Arthritis
    Cohen, Stanley
    Curtis, Jeffrey R.
    DeMasi, Ryan
    Chen, Yan
    Fan, Haiyun
    Soonasra, Arif
    Fleischmann, Roy
    [J]. RHEUMATOLOGY AND THERAPY, 2018, 5 (01) : 283 - 291
12345